Sodium in sodium bicarbonate and sodium phosphates compounded injections

Importance of the Topic

Compounded injections of sodium bicarbonate and sodium phosphates serve critical roles in correcting metabolic acidosis and hypophosphatemia when standard commercial formulations are unsuitable. Accurate sodium quantification in these sterile electrolyte solutions is essential for patient safety and therapeutic efficacy.

Study Objectives and Overview

This application note assesses an ion chromatography (IC) assay validated according to U.S. Pharmacopeia (USP) monographs for determining sodium levels in compounded injections. The focus is on evaluating the Metrosep C Supp 2 – 250/4.0 column with alternative L97 packing as an equivalent to the official USP column.

Methodology and Instrumentation

Sample Preparation:

• Sodium bicarbonate injection: 8.4 g NaHCO₃ dissolved in 100 mL sterile Water for Injection, further diluted 100‐fold to 0.23 mg/mL Na⁺.
• Sodium phosphates injection: 24 g monobasic and 14.2 g dibasic sodium phosphate in 100 mL sterile Water for Injection, diluted 100‐fold to 0.92 mg/mL Na⁺.
• Calibration: single‐point at 0.25 mg/mL Na⁺ using sodium chloride standard.
• All samples prepared in duplicate.

Chromatographic Conditions:

• Column: Metrosep C Supp 2 – 250/4.0 (L97 packing).
• Eluent: 8 mmol/L methanesulfonic acid.
• Flow rate: 1.0 mL/min; temperature: 30 °C; injection volume: 10 µL.
• Detection: suppressed conductivity with sequential suppression using 70 mmol/L sodium carbonate/NaHCO₃ regenerant.

Used Instrumentation

• 930 Compact IC Flex with column oven, sequential suppression, peristaltic pump, and integrated degasser.
• IC Conductivity Detector MB, dynamic range up to 15 000 µS/cm, optimized for microbore columns.
• 919 IC Autosampler plus for automated sample introduction.
• Metrosep C Supp 2 – 250/4.0 column with L97 packing material.

Key Results and Discussion

The method separated sodium in under 12 minutes, with retention near six minutes and peak symmetry (tailing factor <1.8). Precision was high (RSD <1.4% over five replicates). Recovery studies yielded 98–102% sodium for both bicarbonate and phosphate formulations, meeting USP acceptance criteria (95–105%).

Benefits and Practical Applications

This validated IC protocol provides a robust, reliable approach for routine quality control of compounded electrolyte injections. It ensures compliance with pharmacopeial standards and supports safe clinical administration.

Future Trends and Potential Applications

Emerging directions include coupling IC with mass spectrometry for enhanced selectivity, adopting microbore columns to reduce reagent consumption, and integrating automated sample handling for higher throughput in pharmaceutical and clinical laboratories.

Conclusion

The Metrosep C Supp 2 column with L97 packing offers a validated, USP‐compliant method for quantifying sodium in compounded sodium bicarbonate and sodium phosphate injections, combining accuracy, precision, and operational robustness.

References

1. USP General Chapter <797>, Compounding – Sterile Preparations.
2. U.S. Pharmacopeia. Sodium Bicarbonate Compounded Injection Monograph.
3. U.S. Pharmacopeia. Sodium Phosphates Compounded Injection Monograph.
4. USP General Chapter <621>, Chromatography.
5. USP General Chapter <1225>, Validation of Compendial Procedures.